| Tag | Content |
|---|
EnhancerAtlas ID | HS064-01003 |
Organism | Homo sapiens |
Tissue/cell | GM18507 |
Coordinate | chr1:161581620-161583010 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161582212 | 161582506 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | AGATACCCAG GATAAAACGC AGTGTTGACC GATCGAAAAG TCTTTCTCTA AGAATTCAAA 60
CATAATTGCT GGTTGGTTCA AATCAGGAGG AAAAGTAAGG ATGGAAAACA TACGTTGTCA 120
AAAGTGGGAT TCGAACCCAC GCCTCCAGCG GAGGGTGCGA TTTGAACGCA GCGCCTTAAG 180
ACTGCTCGGC CATCCTGACA CACGTTTTGC TAAACTTCCT AATTTCTCCT AATTTTATCA 240
TATACTGATG GTGCACGCTA TCAGGTCACA TTAATGTGTC TATTTACTGT TTCAAATAAA 300
ATTGTAACTC TCTCTAGACC TTGTCGCAAA GCGGGAAAAA TGAAACAGCC TCCGACAGCT 360
CTTTCCTCTT TCCTCACTAC CCAAACTAAA CCTTAAGGCT CCATTTTCCC TGGCGACTCT 420
TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT CGAGCCATGT CAAGGTAGAC CCTGTGTCGG 480
CCCGTCTCCC TCGGATCCTC CGCACCAATC ACTGTTGCTG AATCCGACAC CCGGCGGATC 540
CAGTGCGGAG TCTCGAACAG CTGCGGAGCT GGGAGCTACG GGACATGAGG AGTGCGGGGG 600
GGAAGAGAAG ACGGCGGAGG AAAATCCCCC GGCGGTGCTC AACTGCGGCT TTCTCTCTCG 660
GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC AGAGCAAGTG GCTTCTGCGT TCACCGCCCC 720
CCGCCGTTTG TGGGGCGGGG CCGATTCATA AGAATCGGTT CTCACCAATG GAGGGCTTAG 780
CATGTTTAAC CTCAGGATCA TAAACAAAAG ACACTGCTAG AACGGTCGGG AAAGTCATAC 840
GCTTTGCTTA TCTTATATAT AGATTTCTAA AATTCCAAAC CGGGGACGCG TTGGTGGTGT 900
AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT TAACGCGGGT TCGATTCCCG GGTAACGAAA 960
CGTTTTTGTC TTTCCTTCTA CGAAAAACTT TTCTGAGCCG GAGCCTCCAG CGCGCTGTGT 1020
ATTCGTTTTA CGCCTCAACG AAACTGCAGC AATACCTCAC TTTCCGTACT CGCTTCCTGT 1080
CTTTCCCCTG GCCTCTTTCT AAACCCAGGC TTTTTTTGAA GGGATTAAAT TCTGATGGTT 1140
CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA GGAATCTTTG GGATCATTTC 1200
AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT GTCTTCACTT GCGAGGTTCA 1260
TTCGCTAGCC TCTACAAATC ATCACTTAAG CCCCTAATTA TTCCCGGCCG AGGTCCTAGG 1320
CTAAGGTCCC GGGCCAAGCT TTCTAATTAG TCCCAGGCCA AGGTCCCAGG CCAACCTAAA 1380
TCACGCATTC 1390
|
